Therapy of polycythemia vera: is it time to change?

Oncotarget. 2017 Nov 3;8(61):102759-102760. doi: 10.18632/oncotarget.22282. eCollection 2017 Nov 28.

Authors

Francesco Passamonti¹, Margherita Maffioli¹, Barbara Mora¹

Affiliation

¹ Francesco Passamonti: Department of Medicine and Surgery, Hematology, University of Insubria, Varese, Italy and Ematologia, ASST Sette Laghi-Ospedale di Circolo, Varese, Italy.

No abstract available

Keywords: JAK2; interferon; polycythemia; ruxolitinib.

Publication types

Editorial